Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy

Kamil Stankowski1,2, Stefano Figliozzi1,2, Vincenzo Battaglia1,2

  • 1Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 4, Pieve Emanuele, 20090 Milano, Italy.

PubMed

Insights

Fabry disease (FD) is a genetic disorder causing heart problems. Early diagnosis using cardiac imaging is key for treatment and improving patient outcomes.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Fabry disease (FD) is a genetic lysosomal storage disorder.
  • Cardiovascular involvement is common in FD and impacts clinical outcomes.
  • Early recognition of FD is crucial for timely treatment and improved prognosis.

Purpose of the Study:

  • To review the role of multimodality cardiac imaging in Fabry disease.
  • To explore the diagnostic and prognostic applications of echocardiography and cardiac MRI in FD.
  • To highlight the importance of imaging in differentiating FD from other causes of left ventricular hypertrophy.

Main Methods:

  • Review of current literature on multimodality cardiac imaging in Fabry disease.
  • Focus on echocardiography and cardiovascular magnetic resonance (CMR).
  • Evaluation of imaging's role in diagnosis, prognosis, and patient follow-up.

Main Results:

  • Multimodality imaging is central to evaluating cardiac involvement in FD.
  • Echocardiography and CMR aid in diagnosing FD and assessing its severity.
  • Imaging assists in differentiating FD from other conditions causing left ventricular hypertrophy.

Conclusions:

  • Multimodality cardiac imaging is essential for managing Fabry disease.
  • Early identification of FD through imaging enables timely enzyme replacement therapy.
  • Cardiac imaging improves prognostic assessment and follow-up strategies for FD patients.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
11.5K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
252